The Silver Jubilee (2025) of Insulin Glargine: Introducing the Era of Long-Acting Insulin Analogues for Diabetes Mellitus. [PDF]
Bolli GB +9 more
europepmc +1 more source
Insulin edema in slowly progressive type 1 diabetes: improvement following adjustment of insulin therapy. [PDF]
Okamura E +6 more
europepmc +1 more source
Improved Glycaemic Control with IDegLira in Chinese Adults with Type 2 Diabetes in Real-World Settings: A Retrospective, Database Cohort Study. [PDF]
Wang S +5 more
europepmc +1 more source
Glycemic Efficacy and Safety by Using Insulin Degludec and Aspart Guided by a Clinical Decision Support System in Non-Critically Ill Inpatients with Type 2 Diabetes Mellitus. [PDF]
Aberer F +6 more
europepmc +1 more source
Cost-Effectiveness of Once-Weekly Insulin Icodec versus Daily Basal Insulins in Chinese Adults with T2DM: A Treatment-Background Stratified Analysis. [PDF]
Xie Z +5 more
europepmc +1 more source
Cost-utility of once-weekly insulin icodec versus once-daily basal insulins for type 2 diabetes in China. [PDF]
Tong X, Xing C, Zhang L, Zhang L.
europepmc +1 more source
Lipid level stabilization following combination therapy with IdaGlar and Semaglutide in type 2 diabetes: a retrospective study. [PDF]
Li F, Li J, Liu J.
europepmc +1 more source
Factors associated with impaired hypoglycemia awareness in patients with type 2 diabetes in Korea: a cross-sectional study. [PDF]
Kim JY, Yang Y.
europepmc +1 more source
Efficacy and safety of insulin degludec/insulin aspart biosimilar B01711 vs originator insulin degludec/insulin aspart in Chinese patients with type 2 diabetes inadequately controlled on basal or premixed insulin: A multicenter, randomized, open-label, phase 3 study. [PDF]
Gao L +15 more
europepmc +1 more source
Drug-induced gastric motility disorders: A disproportionality analysis from the FAERS and CVARD databases. [PDF]
Qian Z, Jiang N.
europepmc +1 more source

